Outcomes Following Biochemical or Clinical Progression in Patients with Multiple Myeloma

被引：1
|
作者：
Goldman-Mazur, Sarah [1 ]
Visram, Alissa [1 ,2 ]
Rajkumar, S. Vincent [1 ]
Kapoor, Prashant [1 ]
Dispenzieri, Angela [1 ]
Lacy, Martha Q. [1 ]
Gertz, Morie A. [1 ]
Buadi, Francis K. [1 ]
Hayman, Suzanne R. [1 ]
Dingli, David [1 ]
Kourelis, Taxiarchis [1 ]
Gonsalves, Wilson I. [1 ]
Warsame, Rahma M. [1 ]
Muchtar, Eli [1 ]
Leung, Nelson [1 ]
Kyle, Robert A. [1 ]
Kumar, Shaji [3 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN USA
[2] Ottawa Hosp Res Inst, Div Hematol, Ottawa, ON, Canada
[3] Mayo Clin, Dept Hematol, Rochester, MN USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-149339
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3760
引用
收藏
页码：3760 / +
页数：6
相关论文
共 50 条
  • [1] Outcomes after biochemical or clinical progression in patients with multiple myeloma
    Goldman-Mazur, Sarah
    Visram, Alissa
    Kapoor, Prashant
    Dispenzieri, Angela
    Lacy, Martha Q.
    Gertz, Morie A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Dingli, David
    Kourelis, Taxiarchis
    Gonsalves, Wilson
    Warsame, Rahma
    Muchtar, Eli
    Leung, Nelson
    Binder, Moritz
    Fonder, Amie
    Hobbs, Miriam
    Hwa, Yi Lisa
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    [J]. BLOOD ADVANCES, 2023, 7 (06) : 909 - 917
  • [2] Impact of Clinical Versus Biochemical Progression on Post-Progression Survival in Multiple Myeloma
    Chakraborty, Rajshekhar
    Liu, Hien D.
    Rybicki, Lisa
    Dean, Robert M.
    Faiman, Beth M.
    Kalaycio, Matt
    Khouri, Jack
    Samaras, Christy J.
    Majhail, Navneet S.
    Valent, Jason
    [J]. BLOOD, 2018, 132
  • [3] Clinical outcomes of patients with multiple myeloma following disease progression after BCMA-targeted CAR T-cell therapy
    Subramanian, Naveen G.
    Pleitez, Hector Garcia
    Pasvolsky, Oren
    Kalariya, Nilesh
    Patel, Krina K.
    Ferreri, Christopher J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Clinical Outcomes of Relapsed/Refractory Multiple Myeloma Patients Following Treatment with Bispecific Antibodies (BiAbs)
    Mouhieddine, Tarek H.
    Van Oekelen, Oliver
    Pan, Darren
    Agte, Sarita
    Aleman, Adolfo
    Melnekoff, David T.
    Lancman, Guido
    Thibaud, Santiago
    Sanchez, Larysa
    Richard, Shambavi
    Richter, Joshua
    Cho, Hearn Jay
    Chari, Ajai
    Jagannath, Sundar
    Parekh, Samir
    [J]. BLOOD, 2021, 138
  • [5] Interval Progression Serves As a Predictor of Adverse Outcomes in Patients with Multiple Myeloma
    Bao, Alicia
    Zhao, Qiuhong
    Sharma, Nidhi
    Bumma, Naresh
    Devarakonda, Srinivas
    Khan, Abdullah
    Rosko, Ashley E.
    Benson, Don M., Jr.
    Cottini, Francesca
    [J]. BLOOD, 2021, 138
  • [6] Clinical Outcomes and Salvage Therapies in Patients with Relapsed/Refractory Multiple Myeloma Following Progression on BCMA-Targeted CAR-T Therapy
    Reyes, Kevin R.
    Liu, Yen-Chun
    Huang, Chiung-Yu
    Banerjee, Rahul
    Martin, Thomas
    Shah, Nina
    Wong, Sandy W.
    Wolf, Jeffrey L.
    Arora, Shagun
    Chung, Alfred
    [J]. BLOOD, 2022, 140
  • [7] Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw
    Raje, Noopur
    Woo, Sook-Bin
    Hande, Karen
    Yap, Jeffrey T.
    Richardson, Paul G.
    Vallet, Sonia
    Treister, Nathaniel
    Hideshima, Teru
    Sheehy, Niall
    Chhetri, Shweta
    Connell, Brendan
    Xie, Wanling
    Tai, Yu-Tzu
    Szot-Barnes, Agnieszka
    Tian, Mei
    Schlossman, Robert L.
    Weller, Edie
    Munshi, Nikhil C.
    Van Den Abbeele, Annick D.
    Anderson, Kenneth C.
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (08) : 2387 - 2395
  • [8] HEALTHCARE DISPARITY IN CHANGE IN CLINICAL OUTCOMES IN MULTIPLE MYELOMA PATIENTS
    Gaur, A.
    Mishra, N.
    Kukreja, I
    Pandey, S.
    Daral, S.
    Chopra, A.
    Verma, V.
    Nayyar, A.
    Roy, A.
    Gupta, A.
    Dawar, V
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S452 - S452
  • [9] Clinical Outcomes of Patients with Multiple Myeloma after Daratumumab Failure
    Zamanillo, Irene
    de Alba, Lucia Medina
    Gil, Rodrigo
    de la Puerta, Rosalia
    Alonso, Rafael
    Jimenez-Ubieto, Ana
    Cedena, Maria Teresa
    Calbacho, Maria
    Ayala, Rosa
    Martinez-Lopez, Joaquin
    [J]. LIFE-BASEL, 2023, 13 (09):
  • [10] Age Related Outcomes for Multiple Myeloma Patients Following Autologous Transplantation
    LaPorte, Justin
    Brown, Stacey
    Zhang, Xu
    Bashey, Asad
    Morris, Lawrence E.
    Holland, H. Kent
    Solomon, Scott R.
    [J]. BLOOD, 2014, 124 (21)
12345